John Campbell: New viral vector vaccine
Peer-Reviewed Research
Key Takeaways
- Avoid the Oxford-style viral vector vaccine if possible, as it uses genetically modified chimpanzee adenovirus (similar to AstraZeneca COVID vaccine) linked to severe side effects.
- Prefer traditional antigen vaccines over viral vector/mRNA vaccines when alternatives exist, especially for lower-risk diseases.
- Be aware of autoimmune risks – viral vector vaccines cause your cells to produce foreign antigens, potentially triggering immune attacks on your own tissues.
- Assess risk-benefit carefully – viral vector may be justified for high-mortality diseases like Ebola (30% death rate) but not for lower-risk illnesses.
Notable Quotes
“We know that [the Oxford/AstraZeneca vaccine] caused quite a few side effects… and quite a few people to leave us permanently.”
“I would have preferred to see a traditional antigen vaccine being produced rather than carrying on with this genetically modified viral vector vaccine.”
Bottom Line
Exercise extreme caution with viral vector vaccines (especially Oxford platform), opt for traditional vaccines when available, and demand proper risk-benefit analysis for experimental genetic vaccines.
Explore More
- John Campbell’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network
